TY  - JOUR
AU  - Rodríguez Villodres, Angel
AU  - Gálvez Benítez, Lydia
AU  - Arroyo, Manuel J
AU  - Méndez, Gema
AU  - Mancera, Luis
AU  - Vila Domínguez, Andrea
AU  - Lepe Jímenez, José Antonio
AU  - Smani, Younes
PY  - 2022
DO  - 10.1080/22221751.2022.2113746
UR  - http://hdl.handle.net/10668/19696
T2  - Emerging microbes & infections
AB  - The excessive use of piperacillin/tazobactam (P/T) has promoted the emergence of P/T-resistant Enterobacterales. We reported that in Escherichia coli, P/T contributes to the development of extended-spectrum resistance to β-lactam/β-lactamase inhibitor...
LA  - en
KW  - Escherichia coli
KW  - Piperacillin
KW  - algorithm
KW  - beta-lactamase
KW  - beta-lactamase inhibitor
KW  - machine learning
KW  - resistance
KW  - tazobactam
KW  - Anti-Bacterial Agents
KW  - Escherichia coli
KW  - Escherichia coli Infections
KW  - Humans
KW  - Microbial Sensitivity Tests
KW  - Piperacillin, Tazobactam Drug Combination
KW  - beta-Lactamases
TI  - Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test.
TY  - research article
VL  - 11
ER  -